Anthony Gonzalez1, Christian Hernandez Murcia2, Rey Romero2, Ernesto Escobar2, Pedro Garcia2, Gail Walker3, Michelle Gallas3, Eugene Dickens4, Bruce McIntosh5, William Norwood6, Keith Kim7, Jorge Rabaza2, Don Parris3. 1. Department of General and Bariatric Surgery, Baptist Health South Florida, 7800 SW 87th Av., Suite B210, Miami, FL, 33173, USA. anthonyg@baptisthealth.net. 2. Department of General and Bariatric Surgery, Baptist Health South Florida, 7800 SW 87th Av., Suite B210, Miami, FL, 33173, USA. 3. Population Health and Outcomes Research, Center for Research & Grants, Baptist Health South Florida, Miami, FL, USA. 4. Utica Park Clinic, Tulsa, OK, USA. 5. Premier Surgical Specialists and William Beaumont Hospital, Troy, MI, USA. 6. Norwood Surgical Specialists, Shreveport, LA, USA. 7. Florida Hospitals, Celebration Health, Celebration, FL, USA.
Abstract
BACKGROUND: Recently, the robotic single-site platform has been used to ameliorate the difficulties seen in single-incision laparoscopic surgery (SILC) while preserving the benefits of standard laparoscopic cholecystectomy. The purpose of this study is to describe the clinical outcomes of a large series of single-incision robotic cholecystectomy (SIRC). METHODS: Medical records of consecutive patients who underwent SIRC were retrospectively reviewed. All procedures were performed by six surgeons at five different North American centers involved in the study. All patients included in the study underwent a cholecystectomy attempted through single site at the umbilicus, using the da Vinci(®) Surgical System (Intuitive Surgical Inc. Sunnyvale, CA). RESULTS: A total of 465 patients met study criteria. Median age was 48 years (range 18-89); 351 (75.5 %) were female and 304 (66.4 %) were overweight or obese. Except for gender, case characteristics differed significantly by surgeon/site. Previous abdominal surgery was reported for 226 (48.6 %) cases. SIRC was successfully completed in 455 (97.8 %) cases, and there were no conversions to open surgery. Median surgical time was 52 min with a decreasing trend after 55-85 cases. Male gender, obesity and diagnoses other than biliary dyskinesia were independent predictors of longer surgical times. The complication rate was 2.6 %. CONCLUSIONS: Our large, multicenter study demonstrates that robotic single-site cholecystectomy is safe and feasible in a wide range of patients.
BACKGROUND: Recently, the robotic single-site platform has been used to ameliorate the difficulties seen in single-incision laparoscopic surgery (SILC) while preserving the benefits of standard laparoscopic cholecystectomy. The purpose of this study is to describe the clinical outcomes of a large series of single-incision robotic cholecystectomy (SIRC). METHODS: Medical records of consecutive patients who underwent SIRC were retrospectively reviewed. All procedures were performed by six surgeons at five different North American centers involved in the study. All patients included in the study underwent a cholecystectomy attempted through single site at the umbilicus, using the da Vinci(®) Surgical System (Intuitive Surgical Inc. Sunnyvale, CA). RESULTS: A total of 465 patients met study criteria. Median age was 48 years (range 18-89); 351 (75.5 %) were female and 304 (66.4 %) were overweight or obese. Except for gender, case characteristics differed significantly by surgeon/site. Previous abdominal surgery was reported for 226 (48.6 %) cases. SIRC was successfully completed in 455 (97.8 %) cases, and there were no conversions to open surgery. Median surgical time was 52 min with a decreasing trend after 55-85 cases. Male gender, obesity and diagnoses other than biliary dyskinesia were independent predictors of longer surgical times. The complication rate was 2.6 %. CONCLUSIONS: Our large, multicenter study demonstrates that robotic single-site cholecystectomy is safe and feasible in a wide range of patients.
Entities:
Keywords:
Laparoscopic cholecystectomy; Robotic platform; Single incision
Authors: Anthony Michael Gonzalez; Jorge Rafael Rabaza; Charan Donkor; Rey Jesús Romero; Radomir Kosanovic; Juan Carlos Verdeja Journal: Surg Endosc Date: 2013-08-13 Impact factor: 4.584
Authors: Philippe Morel; Nicolas C Buchs; Pouya Iranmanesh; François Pugin; Leo Buehler; Dan E Azagury; Minoa Jung; Francesco Volonte; Monika E Hagen Journal: J Hepatobiliary Pancreat Sci Date: 2013-10-21 Impact factor: 7.027
Authors: B Balachandran; G Melich; T Mustafa; S J Marecik; L M Prasad; M Gonzalez; S Sulo; F Dabbous; J J Park Journal: Tech Coloproctol Date: 2017-01-31 Impact factor: 3.781
Authors: S Cianci; A Rosati; V Rumolo; S Gueli Alletti; V Gallotta; L C Turco; G Corrado; G Vizzielli; A Fagotti; F Fanfani; G Scambia; S Uccella Journal: World J Surg Date: 2019-10 Impact factor: 3.352
Authors: Anthony Yuen Bun Teoh; Shannon Melissa Chan; Hon Chi Yip; Vivien Wai Yin Wong; Philip Wai Yan Chiu; Enders Kwok Wai Ng Journal: Surg Endosc Date: 2017-08-11 Impact factor: 4.584